ALNY vs FSHPR · P/E 76, rev $1.29B vs rev $2.5M
Alnylam Pharmaceuticals Inc (ALNY) versus Flag Ship Acquisition Corp. Right (FSHPR) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Flag Ship Acquisition Corp. Right (FSHPR) common stock listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported FSHPR revenue for 2025-12-31 was $2.5M. Net income was $1.8M. Revenue was up 38.3% from 2024-12-31 to 2025-12-31. FSHPR currently screens at market cap $0.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. FSHPR currently screens at market cap $0.
Not investment advice. Open the ALNY and FSHPR stock pages for the full models.
Not investment advice.